Robert Toto, MD
Medical Director of the Multi-Specialty Clinic at UT Southwestern Medical Center
Associate Dean for Translational Science and Education
Director of the Center for Translational Medicine
This whiteboard preceptorship is focused on the management of chronic and diabetic kidney disease.
At the completion of this activity, participants will be able to:
- Explain the pathophysiology of CKD and its implications for increased renal and CVD risks in patients with DKD
- Discuss how inflammation, fibrosis and activation of MRs drive the progression of CKD in patients with DKD
- Describe the screening assessments for CDK recommended in evidence-based guidelines that may assist in the early diagnosis of DKD in clinical practice
- Review the mechanisms of action and clinical profiles of new and emerging renoprotective agents for the treatment of DKD
- Use preventive measures to mitigate the risk of hyperkalemia and improve clinical outcomes for patients with DKD receiving MRA therapy
This educational activity is designed for U.S.-based nephrologists, endocrinologists, diabetologists, cardiologists, primary care physicians, and other healthcare professionals with an interest in treating patients with CKD, T2DM, and CVD.
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this activity for a maximum of 1.00 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses who diagnose, treat, and manage patients with CKD, T2DM, and CVD.
Credits: 1.0 ANCC Contact Hour
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.00 contact hour(s) of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF FINANCIAL RELATIONSHIPS
Dr. Toto reports the following relationships: consultant with Akebia, Astra-Zeneca, Bayer, IQVIA, Medscape, Quest Diagnostics, Reata, and Relypsa.
The independent reviewers, staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests:
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff, Planners, and Managers
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
Russie Allen, Outcomes Coordinator for Med Learning Group has nothing to disclose.
Chris Drury, Medical Director, Scientific and Medical Services for Med Learning Group has nothing to disclose.
Amanda Jenkins, Program Coordinator for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, Dr. Toto may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures.
- Participate in the enduring activity.
- Complete and submit the evaluation form to Med Learning Group.
You will receive your certificate after the enduring activity.
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at firstname.lastname@example.org.
For CME questions, please contact Med Learning Group at email@example.com.
RELEASE DATE: November 13, 2020
EXPIRATION DATE: November 13, 2021
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/.
Copyright © 2020 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.